Disney considered "thousands of AI companies" before backing one that keeps the animators in control of the output.

Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...

DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced third quarter 2025 results on November 12th, 2025, and held a conference call to discuss them after ...

APM undergoes leadership changes as it approaches 30 years, focusing on maintaining service standards and company culture.

Twist reported SynBio revenue of $39.5 million for the quarter, a 17% increase year-over-year, and $145 million for the full year. NGS revenue reached $53 million for the quarter and $208.1 million ...

Hence, if you have less than Rs 2 lakhs to spend on a motorcycle with the neo-retro charm and a beefy performance profile, ...

Silicon Valley billionaires love to chase extreme health tech. Their next obsession, after dabbling in tech to reverse aging, ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

From e-health records to a biotech hub in Tartu, Estonia is harnessing data, digital infrastructure, and investment to drive ...

Google’s latest Doodle celebrates DNA, spotlighting the iconic double helix and urging users to explore the science of genetics through Google’s AI-powered search tools.

The company aims to bring its technology — a lab-free detection method for cancers, viruses, and bacteria — to market in 2026 ...

Strong financial position with cash, cash equivalents and marketable securities of $93.7M Moderna litigation U.S. trial scheduled for March 2026;Favorable claim construction ruling in Pfizer-BioNTech ...